Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 49 results.
User Information
Export Records
  1. 1.   The Mirasol Evaluation of Reduction in Infections Trial (MERIT): study protocol for a randomized controlled clinical trial
  2. Kasirye, Ronnie; Hume, Heather A; Bloch, Evan M; Lubega, Irene; Kyeyune, Dorothy; Shrestha, Ruchee; Ddungu, Henry; Musana, Hellen Wambongo; Dhabangi, Aggrey; Ouma, Joseph; Eroju, Priscilla; de Lange, Telsa; Tartakovsky, Michael; White, Jodie L; Kakura, Ceasar; Fowler, Mary Glenn; Musoke, Philippa; Nolan, Monica; Grabowski, M Kate; Moulton, Lawrence H; Stramer, Susan L; Whitby,Denise; Zimmerman, Peter A; Wabwire, Deo; Kajja, Isaac; McCullough, Jeffrey; Goodrich, Raymond; Quinn, Thomas C; Cortes, Robert; Ness, Paul M; Tobian, Aaron A R
  3. Trials. 2022, Apr 04; 23(1):
  1. 2.   Peptide hydrogels for affinity-controlled release of therapeutic cargo: Current and potential strategies
  2. Nambiar,Monessha; Schneider,Joel
  3. Journal of Peptide Science. 2021, Nov 7; e3377.
  1. 3.   Effects of low-to-moderate alcohol supplementation on urinary estrogen metabolites in postmenopausal women in a controlled feeding study.
  2. Mahabir, Somdat; Pfeiffer, Ruth; Xu, Xia; Baer, David J; Taylor, Philip R
  3. Cancer medicine. 2017, Oct; 6(10): 2419-2423.
  1. 4.   Fifty Years of Diazeniumdiolate Research. From Laboratory Curiosity to Broad-Spectrum Biomedical Advances
  2. Keefer, L. K.
  3. Acs Chemical Biology. 2011, Nov; 6(11): 1147-1155.
  1. 5.   Encapsulation of curcumin in self-assembling peptide hydrogels as injectable drug delivery vehicles
  2. Altunbas, A.; Lee, S. J.; Rajasekaran, S. A.; Schneider, J. P.; Pochan, D. J.
  3. Biomaterials. 2011, Sep; 32(25): 5906-5914.
  1. 6.   Isolated and Skeptical: Social Engagement and Trust in Information Sources Among Smokers
  2. Rutten, L. J. F.; Blake, K.; Hesse, B. W.; Ackerson, L. K.
  3. Journal of Cancer Education. 2011, Sep; 26(3): 465-473.
  1. 7.   One Percent Tenofovir Applied Topically to Humanized BLT Mice and Used According to the CAPRISA 004 Experimental Design Demonstrates Partial Protection from Vaginal HIV Infection, Validating the BLT Model for Evaluation of New Microbicide Candidates
  2. Denton, P. W.; Othieno, F.; Martinez-Torres, F.; Zou, W.; Krisko, J. F.; Fleming, E.; Zein, S.; Powell, D. A.; Wahl, A.; Kwak, Y. T.; Welch, B. D.; Kay, M. S.; Payne, D. A.; Gallay, P.; Appella, E.; Estes, J. D.; Lu, M.; Garcia, J. V.
  3. Journal of Virology. 2011, Aug; 85(15): 7582-7593.
  1. 8.   Prevalence of Etravirine-Associated Mutations in Clinical Samples With Genotypic Resistance to Nevirapine and Efavirenz in Brazilian Clinics
  2. Martins, A. N.; Arruda, M. B.; Aleixo, A. W.; Pires, A. F.; Greco, D. B.; Brindeiro, R. D.; Tanuri, A.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2011, Aug; 57: S193-S196.
  1. 9.   Ductal Carcinoma In Situ: Detection, Diagnosis, and Characterization with Magnetic Resonance Imaging
  2. Jansen, S. A.
  3. Seminars in Ultrasound Ct and Mri. 2011, Aug; 32(4): 306-318.
  1. 10.   The Nonnucleoside Reverse Transcriptase Inhibitor MIV-150 in Carrageenan Gel Prevents Rectal Transmission of Simian/Human Immunodeficiency Virus Infection in Macaques
  2. Singer, R.; Derby, N.; Rodriguez, A.; Kizima, L.; Kenney, J.; Aravantinou, M.; Chudolij, A.; Gettie, A.; Blanchard, J.; Lifson, J. D.; Piatak, M.; Fernandez-Romero, J. A.; Zydowsky, T. M.; Robbiani, M.
  3. Journal of Virology. 2011, Jun; 85(11): 5504-5512.
  1. 11.   Twice-weekly pegylated interferon-alpha-2a and ribavirin results in superior viral kinetics in HIV/hepatitis C virus co-infected patients compared to standard therapy
  2. Murphy, A. A.; Herrmann, E.; Osinusi, A. O.; Wu, L.; Sachau, W.; Lempicki, R. A.; Yang, J.; Chung, T. L.; Wood, B. J.; Haagmans, B. L.; Kottilil, S.; Polis, M. A.
  3. Aids. 2011, Jun; 25(9): 1179-1187.
  1. 12.   Anti-HIV microbicide development: targeting the virus is the key
  2. O'Keefe, B. R.
  3. Future Virology. 2011, May; 6(5): 553-556.
  1. 13.   Newkome-Type Dendron-Stabilized Gold Nanoparticles: Synthesis, Reactivity, and Stability
  2. Cho, T. J.; Zangmeister, R. A.; MacCuspie, R. I.; Patri, A. K.; Hackley, V. A.
  3. Chemistry of Materials. 2011, May; 23(10): 2665-2676.
  1. 14.   TLR-based immune adjuvants
  2. Steinhagen, F.; Kinjo, T.; Bode, C.; Klinman, D. M.
  3. Vaccine. 2011, Apr; 29(17): 3341-3355.
  1. 15.   Suppression of inflammation in ulcerative colitis by interferon-beta-1a is accompanied by inhibition of IL-13 production
  2. Mannon, P. J.; Hornung, R. L.; Yang, Z. Q.; Yi, C. L.; Groden, C.; Friend, J.; Yao, M.; Strober, W.; Fuss, I. J.
  3. Gut. 2011, Apr; 60(4): 449-455.
  1. 16.   Mechanisms of HIV-1 drug resistance to nucleoside and nonnucleoside reverse transcriptase inhibitors
  2. Nikolenko, G. N.; Kotelkin, A. T.; Oreshkova, S. F.; Ilyichev, A. A.
  3. Molecular Biology. 2011, Feb; 45(1): 93-109.
  1. 17.   An Antiretroviral/Zinc Combination Gel Provides 24 Hours of Complete Protection against Vaginal SHIV Infection in Macaques
  2. Kenney, J.; Aravantinou, M.; Singer, R.; Hsu, M.; Rodriguez, A.; Kizima, L.; Abraham, C. J.; Menon, R.; Seidor, S.; Chudolij, A.; Gettie, A.; Blanchard, J.; Lifson, J. D.; Piatak, M.; Fernandez-Romero, J. A.; Zydowsky, T. M.; Robbiani, M.
  3. Plos One. 2011, Jan; 6(1): 10.
  1. 18.   Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC
  2. Stockwin, L. H.; Yu, S. X.; Borgel, S.; Hancock, C.; Wolfe, T. L.; Phillips, L. R.; Hollingshead, M. G.; Newton, D. L.
  3. International Journal of Cancer. 2010, Dec; 127(11): 2510-2519.
  1. 19.   ANTIVIRAL COMPOUNDS IN THE PIPELINE TO TACKLE H1N1 INFLUENZA INFECTION
  2. Beigel, J. H.
  3. Drugs of the Future. 2010, May; 35(5): 385-392.
  1. 20.   Kinetics of Serum Cytokines after Primary or Repeat Vaccination with the Smallpox Vaccine
  2. Cohen, J. I.; Hohman, P.; Fulton, R.; Turk, S. P.; Qin, J.; Thatcher, K.; Hornung, R. L.
  3. Journal of Infectious Diseases. 2010, Apr; 201(8): 1183-1191.
  1. 21.   The NCI Thesaurus quality assurance life cycle
  2. de Coronado, S.; Wright, L. W.; Fragoso, G.; Haber, M. W.; Hahn-Dantona, E. A.; Hartel, F. W.; Quan, S. L.; Safran, T.; Thomas, N.; Whiteman, L.
  3. Journal of Biomedical Informatics. 2009 42(3): 530-539.
  1. 22.   Gene Expression Patterns Induced by HPV-16 L1 Virus-Like Particles in Leukocytes from Vaccine Recipients
  2. Garcia-Pineres, A. J.; Hildesheim, A.; Dodd, L.; Kemp, T. J.; Yang, J.; Fullmer, B.; Harro, C.; Lowy, D. R.; Lempicki, R. A.; Pinto, L. A.
  3. Journal of Immunology. 2009 182(3): 1706-1729.
  1. 23.   The effect of continuous versus pericycle antiretroviral therapy on IL-2 responsiveness
  2. Healey, L. M.; Hahn, B. K.; Rehm, C. A.; Adelsberger, J.; Qin, J.; Follmann, D. A.; Tavel, J.; Kovacs, J. A.; Sereti, I.; Davey, R. T.
  3. Journal of Interferon and Cytokine Research. 2008 28(7): 455-461.
  1. 24.   Evaluation of two types of sponges used to collect cervical secretions and assessment of antibody extraction protocols for recovery of neutralizing anti-human papillomavirus type 16 antibodies
  2. Kemp, T. J.; Hildesheim, A.; Falk, R. T.; Schiller, J. T.; Lowy, D. R.; Rodriguez, A. C.; Pinto, L. A.
  3. Clinical and Vaccine Immunology. 2008 15(1): 60-64.
  1. 25.   CD4 T cell survival after intermittent interleukin-2 therapy is predictive of an increase in the CD4 T cell count of HIV-infected patients
  2. Read, S. W.; Lempicki, R. A.; Di Mascio, M.; Srinivasula, S.; Burke, R.; Sachau, W.; Bosche, M.; Adelsberger, J. W.; Sereti, I.; Davey, R. T.; Tavel, J. A.; Huang, C. Y.; Issaq, H. J.; Fox, S. D.; Lane, H. C.; Kovacs, J. A.
  3. Journal of Infectious Diseases. 2008 198(6): 843-850.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel